Company Listing
VenatoRx

VenatoRx is a biopharmaceutical company developing next generation antibiotics to combat the threat of antibiotic resistance. The company’s lead product is a novel β-lactamase inhibitor in clinical trials that directly inhibits all four major classes of beta-lactamases. In addition to this clinical lead, VenatoRx has a broad pipeline of preclinical programmes.

BACK
Location
Malvern, PA
CEO
Christopher J. Burns
Abingworth Partner
Shelley Chu
Website Address

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

VenatoRx is a biopharmaceutical company developing next generation antibiotics to combat the threat of antibiotic resistance. The company’s lead product is a novel β-lactamase inhibitor in clinical trials that directly inhibits all four major classes of beta-lactamases. In addition to this clinical lead, VenatoRx has a broad pipeline of preclinical programmes.

Location
Malvern, PA
CEO
Christopher J. Burns
Abingworth Partner
Shelley Chu
Website Address
BACK
 
Copyright Abingworth 2017